A drug-eluting stent (DES) is a cardiac device that releases medications slowly into peripheral or coronary arteries to prevent cell proliferation and improve blood flow. A metallic stent, polymer covering, and anti-restenosis medication make up the device. The stent is coated with drugs that help keep the arteries smooth and allow enough blood to circulate. DES is a drug that is commonly used to treat cardiac artery blockages, prevent plaque accumulation, blood clots, and lessen the need for revascularization. The stent is minimally invasive (MI) and reduces the requirement for long-term dual antiplatelet therapy by lowering restenosis rates, improving vascular healing, and reducing the need for dual antiplatelet therapy.
Increased demand for drug eluting stents is likely to propel global Drug Eluting Stents Market growth over the forecast period, owing to an increase in the incidence of cardiovascular disease. Furthermore, poor eating habits, lack of exercise, and sedentary lifestyles are key contributors to the rise in the prevalence of cardiovascular disease, which leads to an increase in mortality rates. According to the American Heart Association (AHA), around 801,000 fatalities were reported owing to cardiovascular diseases in the United States in 2016, and approximately 92.1 million adults in the United States suffered from some type of cardiovascular disease. Furthermore, according to the same source, coronary heart disease is responsible for 45.1 percent of deaths in the United States and roughly 31% of global deaths.
Read more @ https://cmiaspireblog.blogspot.com/2022/03/drug-eluting-stents-market-size-share.html
